Owner Cytimmune Sciences, Inc.

Inventors Paciotti, Giulio F; Tamarkin, Lawrence

Agent FB Rice

Pub. Number AU-B-2007200363

Parent 2002259107

Filing date 29 January 2007

Wipo publication date 22 February 2007

Acceptance publication date 9 October 2008

A61P 35/00 (2006.01) Antineoplastic agents

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 38/46 (2006.01) Medicinal preparations containing peptides

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 14/525 (2006.01) Peptides having more than 20 amino acids

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins